BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 19383573)

  • 21. The metabolic syndrome - an ongoing story.
    Duvnjak L; Duvnjak M
    J Physiol Pharmacol; 2009 Dec; 60 Suppl 7():19-24. PubMed ID: 20388942
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Very severely obese patients have a high prevalence of type 2 diabetes mellitus and cardiovascular disease.
    Vinciguerra F; Baratta R; Farina MG; Tita P; Padova G; Vigneri R; Frittitta L
    Acta Diabetol; 2013 Jun; 50(3):443-9. PubMed ID: 23447004
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Obesity and metabolic syndrome: potential benefit from specific nutritional components.
    Abete I; Goyenechea E; Zulet MA; Martínez JA
    Nutr Metab Cardiovasc Dis; 2011 Sep; 21 Suppl 2():B1-15. PubMed ID: 21764273
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiovascular metabolic syndrome - an interplay of, obesity, inflammation, diabetes and coronary heart disease.
    Rana JS; Nieuwdorp M; Jukema JW; Kastelein JJ
    Diabetes Obes Metab; 2007 May; 9(3):218-32. PubMed ID: 17391148
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiovascular risk factors are really linked in the metabolic syndrome: this phenomenon suggests clustering rather than coincidence.
    Aizawa Y; Kamimura N; Watanabe H; Aizawa Y; Makiyama Y; Usuda Y; Watanabe T; Kurashina Y
    Int J Cardiol; 2006 May; 109(2):213-8. PubMed ID: 16023231
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Metabolic syndrome in childhood and adolescence].
    Barkai L; Paragh G
    Orv Hetil; 2006 Feb; 147(6):243-50. PubMed ID: 16610614
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of 1-year treatment with metformin on metabolic and cardiovascular risk factors in non-diabetic upper-body obese subjects with mild glucose anomalies: a post-hoc analysis of the BIGPRO1 trial.
    Fontbonne A; Diouf I; Baccara-Dinet M; Eschwege E; Charles MA
    Diabetes Metab; 2009 Nov; 35(5):385-91. PubMed ID: 19665415
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolic syndrome: an all or none or a continuum load of risk?
    Cubeddu LX; Hoffmann IS
    Metab Syndr Relat Disord; 2012 Feb; 10(1):14-9. PubMed ID: 22032809
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of postpartum carbohydrate intolerance and cardiovascular risk factors in women with gestational diabetes.
    Akinci B; Celtik A; Genc S; Yener S; Demir T; Secil M; Kebapcilar L; Yesil S
    Gynecol Endocrinol; 2011 May; 27(5):361-7. PubMed ID: 20540676
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of non-traditional cardiovascular disease risk factors among persons with impaired fasting glucose, impaired glucose tolerance, diabetes, and the metabolic syndrome: analysis of the Third National Health and Nutrition Examination Survey (NHANES III).
    Muntner P; He J; Chen J; Fonseca V; Whelton PK
    Ann Epidemiol; 2004 Oct; 14(9):686-95. PubMed ID: 15380800
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The metabolic syndrome as a cluster of risk factors: is the whole greater than the sum of its parts?: comment on "The metabolic syndrome, its component risk factors, and progression of coronary atherosclerosis".
    Ding EL; Smit LA; Hu FB
    Arch Intern Med; 2010 Mar; 170(5):484-5. PubMed ID: 20212187
    [No Abstract]   [Full Text] [Related]  

  • 32. A novel component of the metabolic syndrome: the oxidative stress.
    Hopps E; Noto D; Caimi G; Averna MR
    Nutr Metab Cardiovasc Dis; 2010 Jan; 20(1):72-7. PubMed ID: 19747805
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The insulin resistance syndrome: mechanisms of clustering of cardiovascular risk.
    Chan JC; Tong PC; Critchley JA
    Semin Vasc Med; 2002 Feb; 2(1):45-57. PubMed ID: 16222595
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationships among insulin resistance, obesity, diagnosis of the metabolic syndrome and cardio-metabolic risk.
    Salazar MR; Carbajal HA; Espeche WG; Dulbecco CA; Aizpurúa M; Marillet AG; Echeverría RF; Reaven GM
    Diab Vasc Dis Res; 2011 Apr; 8(2):109-16. PubMed ID: 21562062
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interplay of vitamin D and metabolic syndrome: A review.
    Prasad P; Kochhar A
    Diabetes Metab Syndr; 2016; 10(2):105-12. PubMed ID: 25813139
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Metabolic syndrome: limited significance for clinical practice].
    Dekker JM; Diamant M; Nijpels G; Heine RJ
    Ned Tijdschr Geneeskd; 2005 Apr; 149(16):855-8. PubMed ID: 15868988
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolic syndrome in young people.
    Poyrazoglu S; Bas F; Darendeliler F
    Curr Opin Endocrinol Diabetes Obes; 2014 Feb; 21(1):56-63. PubMed ID: 24247648
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Questions in diabetology to be elucidated].
    Simon K; Dobó E; Szépvölgyi A; Szalczer E; Kazup S; Papp L; Varga E
    Orv Hetil; 2011 Aug; 152(34):1353-61. PubMed ID: 21835741
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Metabolic syndrome as a precursor of diabetes mellitus type 2 and cardiovascular diseases].
    Shestakova MV; Butrova SA; Sukhareva OIu
    Ter Arkh; 2007; 79(10):5-8. PubMed ID: 18154136
    [No Abstract]   [Full Text] [Related]  

  • 40. The link between abdominal obesity, metabolic syndrome and cardiovascular disease.
    Ritchie SA; Connell JM
    Nutr Metab Cardiovasc Dis; 2007 May; 17(4):319-26. PubMed ID: 17110092
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.